These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 34745851)
1. CRISPR-Cas9: A method for establishing rat models of drug metabolism and pharmacokinetics. Lu J; Liu J; Guo Y; Zhang Y; Xu Y; Wang X Acta Pharm Sin B; 2021 Oct; 11(10):2973-2982. PubMed ID: 34745851 [TBL] [Abstract][Full Text] [Related]
2. Characterization of organic anion transporting polypeptide 1b2 knockout rats generated by CRISPR/Cas9: a novel model for drug transport and hyperbilirubinemia disease. Ma X; Shang X; Qin X; Lu J; Liu M; Wang X Acta Pharm Sin B; 2020 May; 10(5):850-860. PubMed ID: 32528832 [TBL] [Abstract][Full Text] [Related]
3. CRISPR-Cas system enables fast and simple genome editing of industrial Stovicek V; Borodina I; Forster J Metab Eng Commun; 2015 Dec; 2():13-22. PubMed ID: 34150504 [TBL] [Abstract][Full Text] [Related]
4. [Advances in CRISPR/Cas9-mediated gene editing]. Li C; Cao W Sheng Wu Gong Cheng Xue Bao; 2015 Nov; 31(11):1531-42. PubMed ID: 26939437 [TBL] [Abstract][Full Text] [Related]
5. [Recent developments in enhancing the efficiency of CRISPR/Cas9- mediated knock-in in animals]. Li GL; Yang SX; Wu ZF; Zhang XW Yi Chuan; 2020 Jul; 42(7):641-656. PubMed ID: 32694104 [TBL] [Abstract][Full Text] [Related]
6. Gene Editing With TALEN and CRISPR/Cas in Rice. Bi H; Yang B Prog Mol Biol Transl Sci; 2017; 149():81-98. PubMed ID: 28712502 [TBL] [Abstract][Full Text] [Related]
7. Gene Editing in Clinical Practice: Where are We? Mittal RD Indian J Clin Biochem; 2019 Jan; 34(1):19-25. PubMed ID: 30728669 [TBL] [Abstract][Full Text] [Related]
8. Application of genome editing technologies to the study and treatment of hematological disease. Pellagatti A; Dolatshad H; Yip BH; Valletta S; Boultwood J Adv Biol Regul; 2016 Jan; 60():122-134. PubMed ID: 26433620 [TBL] [Abstract][Full Text] [Related]
13. Targeted mutagenesis: A sniper-like diversity generator in microbial engineering. Zheng X; Xing XH; Zhang C Synth Syst Biotechnol; 2017 Jun; 2(2):75-86. PubMed ID: 29062964 [TBL] [Abstract][Full Text] [Related]
14. CRISPR-Cas9 system: A new-fangled dawn in gene editing. Gupta D; Bhattacharjee O; Mandal D; Sen MK; Dey D; Dasgupta A; Kazi TA; Gupta R; Sinharoy S; Acharya K; Chattopadhyay D; Ravichandiran V; Roy S; Ghosh D Life Sci; 2019 Sep; 232():116636. PubMed ID: 31295471 [TBL] [Abstract][Full Text] [Related]
15. Designed nucleases for targeted genome editing. Lee J; Chung JH; Kim HM; Kim DW; Kim H Plant Biotechnol J; 2016 Feb; 14(2):448-62. PubMed ID: 26369767 [TBL] [Abstract][Full Text] [Related]
16. CRISPR/Cas9-mediated correction of human genetic disease. Men K; Duan X; He Z; Yang Y; Yao S; Wei Y Sci China Life Sci; 2017 May; 60(5):447-457. PubMed ID: 28534256 [TBL] [Abstract][Full Text] [Related]
17. Dramatic Improvement of CRISPR/Cas9 Editing in Ng H; Dean N mSphere; 2017; 2(2):. PubMed ID: 28435892 [TBL] [Abstract][Full Text] [Related]
18. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure. Soriano V AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352 [TBL] [Abstract][Full Text] [Related]
19. Clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein 9 with improved proof-reading enhances homology-directed repair. Kato-Inui T; Takahashi G; Hsu S; Miyaoka Y Nucleic Acids Res; 2018 May; 46(9):4677-4688. PubMed ID: 29672770 [TBL] [Abstract][Full Text] [Related]
20. CRISPR-Cas9 fusion to dominant-negative 53BP1 enhances HDR and inhibits NHEJ specifically at Cas9 target sites. Jayavaradhan R; Pillis DM; Goodman M; Zhang F; Zhang Y; Andreassen PR; Malik P Nat Commun; 2019 Jun; 10(1):2866. PubMed ID: 31253785 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]